Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

151.09 -4.06 (-2.62%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina Inc

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Single-Cell Analysis Market Worth $6.3 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global single-cell analysis market is projected to reach $6.3 billion by 2026. Single cell data analysis market report provides crucial industry insights that will help your business grow. 
Via SBWire
Illumina Named #1 for Workers in Its Industry by JUST Capital
SOURCE: Illumina 
Via 3BL Media
Genomics Market worth $54.4 billion by 2025 | Key Players are Illumina, Inc. (US),Thermo Fisher Scientific (US) QIAGEN N.V. (Netherlands)
Via AB Newswire
Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Emissions
Exposures Climate
Illumina, Inc. (NASDAQ:ILMN) Investor Alert: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 09/08/2021 -- Illumina, Inc is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Illumina slides after 'Confusing' close of Grail deal amid antitrust probe
Citi sees some risk that Illumina's tactic does not sit well with the regulatory bodies. 
Via Talk Markets
Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay
Illumina Inc (NASDAQ: ILMN) and Merck & Co Inc (NYSE: MRK) provided more details on their partnership to develop and commercialize tests that gauge... 
Via Benzinga
Why Illumina Wants Grail Back So Badly
The gene-sequencing giant sees a huge opportunity in diagnostics. 
Via The Motley Fool
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing. 
Via InvestorPlace
Agrigenomics Market Emerging Trends and Recent Developments
Northbrook, IL -- (SBWIRE) -- 09/02/2021 -- Agrigenomics Market by Application (Crops and Livestock), Sequencer Type (Sanger Sequencing, Illumina HiSeq Family, PacBio Sequencer, SOLiD Sequencer),... 
Via SBWire
Exposures Ethanol
Illumina Genomic Discoveries Program Brings Sophisticated Lab Experiences to High School Classrooms
SOURCE: Illumina 
Via 3BL Media
Berry Oncology Utilizes Illumina Technology to Accelerate Early Liver Cancer Detection in China
SOURCE: Illumina 
Via 3BL Media
Workday And Lam Research Lead The QQQ
U.S. indices were trading higher Friday as investors eye Fed Chairman Powell's speech at the Jackson Hole Symposium and gauge Fed tapering policy. The Invesco QQQ Trust... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Illumina’s Shanghai Family Day Educates Kids on DNA and STEM Activities
SOURCE: Illumina 
Via 3BL Media
Looking into Illumina's Return on Capital Employed
Pulled from Benzinga Pro data Illumina (NASDAQ:ILMN) showed a loss in earnings since Q1, totaling $187.00 million. Sales, on the other hand, increased by 3.02% to $1.13 billion... 
Via Benzinga
Friday Fears and Other Stock News Updates
Toyota has cut its output 40% over fear of the Delta variant of Covid, plus shortages of electronics. This is terrifying markets outside the USA. And other global stock news updates. 
Via Talk Markets
Illumina's Interns Contribute Over 800 Hours on Social Impact Projects
SOURCE: Illumina 
Via 3BL Media
58 Biggest Movers From Yesterday
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently... 
Via Benzinga
Microsoft And Cisco Gain As The QQQ Bounces Back Thursday
U.S. indices bounced back Thursday after falling Wednesday amid macro uncertainty due to COVID-19 delta variant concerns. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained... 
Via Benzinga
Exposures COVID-19
Why Illumina Stock Just Dropped 10%
The genetic-testing company just blatantly defied its regulators. 
Via The Motley Fool
38 Stocks Moving In Thursday's Mid-Day Session
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial... 
Via Benzinga
Illumina Stock Nosedives After DNA Giant Makes A 'Maverick Move' In Its Grail Takeover
Illumina stock tumbled Thursday after the company finished its $8 billion acquisition of Grail despite an ongoing investigation in Europe. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021
Upgrades According to DA Davidson, the prior rating for PaySign Inc (NASDAQ: 
Via Benzinga
Illumina Completes Grail Buyout Despite Uncertainty In Regulatory Process
In defiance of FTC and EU scrutiny, Illumina Inc (NASDAQ: ILMN) went ahead to complete its $8 billion acquisition of Grail. The finalization of the buyout... 
Via Benzinga
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
SOURCE: Illumina 
Via 3BL Media
Topics Death Regulatory Compliance
Exposures COVID-19 Death Legal
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All
Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All 
Via News Direct
Topics Product Recall
Exposures Legal Product Safety
Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All
SOURCE: Illumina 
Via 3BL Media
Topics Product Recall
Exposures Legal Product Safety
Illumina Stock Earns Membership In Elite Club
Illumina saw its IBD SmartSelect Composite Rating rise to 97 Tuesday, up from 93 the day before. 
Via Investor's Business Daily
CD Genomics Launched Viral Genome Sequencing Service to Help Scientists Fight Against Viruses
Via Get News
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.